卵巢癌生存率的种族和民族差异在SEER注册州间的比较
基于SEER 17数据库2000-2022年103,554例上皮性卵巢癌、输卵管癌和原发性腹膜癌病例,采用多变量调整Cox比例风险模型分析不同种族和民族卵巢癌特异性生存的差异。西班牙裔病例生存相似,非西班牙裔亚裔生存优于非西班牙裔白人,非西班牙裔黑人除肯塔基州和爱荷华州外生存较差,非西班牙裔夏威夷/太平洋岛民生存较差,差异在地理上一致。
要点
- 非西班牙裔亚裔卵巢癌特异性生存优于非西班牙裔白人,异质性I²=0.0%。
- 非西班牙裔黑人总体生存较差,但肯塔基州HR 1.01(95%CI 0.84-1.23)和爱荷华州HR 0.82(95%CI 0.55-1.22)例外。
- 非西班牙裔夏威夷/太平洋岛民生存较差,异质性I²=0.0%。
核心结论
- 卵巢癌特异性生存的种族和民族差异持续存在且在地理上一致,提示广泛的多层次决定因素而非州特异性因素,强调需要国家层面努力确保平等获得高质量医疗保健。
研究设计与样本
- 使用SEER 17数据(2000-2022年)构建103,554例上皮性卵巢癌、输卵管癌和原发性腹膜癌病例队列。
- 自我报告的种族与NAACCR西班牙裔识别算法变量交叉分类创建种族和民族组。
- 采用多变量调整Cox比例风险模型估计卵巢癌特异性生存的风险比(HR)和95%置信区间(CI),总体及按注册州、组织学类型、分期和治疗分层,调整先验协变量。
- 使用I统计量评估地理异质性,敏感性分析限于高级别浆液性肿瘤。
主要发现
- 西班牙裔病例卵巢癌特异性生存与非西班牙裔白人相似。
- 非西班牙裔亚裔病例卵巢癌特异性生存优于非西班牙裔白人(I²=0.0%,p-het 0.52)。
- 非西班牙裔黑人病例总体生存较非西班牙裔白人差,但肯塔基州(HR 1.01;95%CI 0.84-1.23)和爱荷华州(HR 0.82;95%CI 0.55-1.22)除外。
- 非西班牙裔夏威夷/太平洋岛民病例生存较非西班牙裔白人差(I²=0.0%;p-het 0.60)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether racial and ethnic differences in ovarian cancer survival exist across states, represented in National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database, and assess whether racial and ethnic differences in ovarian cancer survival differed by factors associated with ovarian cancer prognosis. METHODS: Using SEER 17 data (2000-2022), we constructed a cohort of 103,554 epithelial ovarian, fallopian tube, and primary peritoneal cancer cases. Self-reported race was cross-classified with the NAACCR Hispanic Identification Algorithm variable to create racial and ethnic groups. Multivariable adjusted Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for ovarian cancer-specific survival by race and ethnicity, overall and stratified by registry state, histotype, stage, and treatment, adjusting for a priori covariates. Geographic heterogeneity was assessed using the I-statistic. Sensitivity analyses were restricted to high-grade serous tumors. RESULTS: Hispanic cases had similar ovarian cancer-specific survival, while Non-Hispanic (NH) Asian cases exhibited better ovarian cancer-specific survival than NH White cases across SEER registry states (I2 = 40.2%, p-het 0.08; I2 = 0.0%, p-het 0.52; respectively). NH Black cases generally had worse survival than NH White cases, except in Kentucky (HR: 1.01; 95%CI: 0.84-1.23) and Iowa (HR: 0.82; 95%CI: 0.55-1.22). NH Native Hawaiian/PI cases also had worse survival compared with NH White cases across SEER registry states (I2 = 0.0%; p-het 0.60). CONCLUSION(S): Racial and ethnic disparities in ovarian cancer-specific survival are persistent and geographically consistent, suggesting broad, multi-level determinants rather than state-specific factors underscoring the need for national efforts to ensure uniform access to high-quality healthcare.
引用
- Dunlap CE, Meade CE, Sinnott JA, et al. Racial and ethnic differences in ovarian cancer survival across SEER registry states. Gynecol Oncol. 2026. PMID: 43019613. doi:10.1016/j.ygyno.2026.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。